Healthtech is one of the most difficult industries to build a brand in. You are selling to skeptical buyers: hospital systems, payers, employers, and patients, in a regulated space where trust is the product. The wrong PR agency can change your brand's whole trajectory.
The good news is that we have outlined the criteria for choosing the right agency for your startup. This guide walks through what actually matters when evaluating PR and marketing partners for a healthtech startup, what red flags to watch for, and what strong specialist support looks like in practice.
The core problem: Most agencies pitch healthcare experience, but very few have the depth to handle the regulatory nuance, the media relationships, and the investor visibility that a venture-backed healthtech company needs simultaneously. At BAM, healthtech is one of our core verticals, and the questions we hear most from founders evaluating agencies shaped this guide.
Healthtech is a crowded and complicated space. Your buyers are skeptical, your regulatory environment is unforgiving, and your narrative has to do multiple jobs at once: build credibility with clinical buyers, drive recruitment and partnership conversations, and support your fundraising timeline. Most agencies are not built to do all three simultaneously.
When you get to the evaluation stage of seeking PR help, most agencies will show you media coverage samples, a client list, and a proposed strategy. None of that tells you what you need to know. Use these four criteria instead.
Healthtech is a tough space. The right agency does not just place stories, it builds Narrative Capital: a compounding body of coverage, positioning, and credibility that makes your company harder to ignore over time. That requires strategic experience across the full arc of a startup, from initial industry framing at seed through enterprise credibility at Series A and beyond.
Ask how long the agency has been doing this specifically for venture-backed tech companies, and whether they can show you how a client's narrative evolved over multiple stages. Eighteen years of that work looks very different from two. For a deeper look at what narrative-driven PR actually looks like in practice, BAM's guide to narrative-driven PR for venture-backed startups breaks down the full framework.
Securing a media placement is just the starting point. The agencies that drive real results treat every piece of coverage as an asset to be maximized, pushing it across social platforms, earned media channels, and directly in front of the customers, partners, and investors who need to see it.
If an agency's workflow ends when the article goes live, you are leaving most of the value on the table. Look for partners with a deliberate amplification layer built into their process, not offered as an optional add-on.
Healthtech coverage lives across three distinct media ecosystems: health and clinical publications, tech and startup press, and investor-facing outlets. A strong PR agency has genuine relationships across all three.
This matters because your narrative needs to do different jobs simultaneously. Clinical press builds credibility with buyers, tech press drives recruitment and partnership conversations, and investor outlets support your fundraising narrative.
BAM's media relationships extend beyond inboxes and media lists. Clients get priority access to 40+ invite-only events annually, putting them in the same rooms as the reporters covering their beat. Those conversations accelerate coverage, deepen relationships, and create the kind of ongoing visibility that a cold pitch never can.
If you are venture-backed at seed or Series A, your PR strategy is also your fundraising strategy. The founders who raise their next round fastest are usually the ones whose names appear regularly in the outlets their target investors read, and who show up at the events where those investors are present.
Ask any prospective agency what their VC network looks like. Can they get your story in front of the funds relevant to your stage and sector? Do they have access to invite-only events where those conversations happen in person? This is not a standard PR capability. Most agencies do not offer it.
BAM does, and the results are measurable. According to BAM's own research, venture-backed clients that work with BAM raise funding 41% faster than the industry average. Clients get priority access to 40+ invite-only events annually, putting healthtech founders in the same rooms as the investors evaluating their industry and the partners who can accelerate their next stage. Combined with a close network of 430+ VC funds, BAM treats investor visibility and PR as a single integrated strategy. You can read the full findings in BAM's funding report.
Some warning signs are easy to miss when you are evaluating agencies under time pressure.
The best healthtech PR and marketing partners are built around all four of the criteria above, not just one or two. In practice, that means a specific combination of capabilities working together.
They build narrative capital over time, not just placements in the moment. That means strategic story development from the earliest stage, with a clear through-line from seed positioning to Series A credibility to enterprise brand authority. As we always say: The story compounds, and so does the trust it builds with buyers, partners, and investors.
The best PR partners treat every placement as an asset to be maximized. Coverage gets pushed across social platforms, earned media channels, and directly in front of the customers and investors who need to see it. The placement is the starting point, not the deliverable.
They operate across all three media ecosystems simultaneously, with a clear strategy for how each type of coverage serves a different business objective. Clinical press builds buyer credibility. Tech press drives recruitment and partnership conversations. Investor outlets support the fundraising narrative.
And they connect PR directly to investor visibility, because for venture-backed healthtech companies, those two things are the same strategy.
BAM is one example of what this looks like in practice. We work exclusively with venture-backed tech companies, healthtech included, and bring 18 years of media relationships across health, tech, and investor press. Our network includes 430+ VC funds and priority access to 40+ invite-only events annually.
The work we do speaks for itself. When XCaliber Health, an agentic operating system built for healthcare, came out of stealth following its $6.5 million seed round, BAM secured an exclusive placement in MobiHealthNews, one of the most-read outlets covering digital health funding and innovation. The pitch was built around clinical outcomes and customer validation. You can hear BAM's Senior Account Director Briana Trulear walk through exactly how it was done on The Press Playbook, and see the full range of BAM's healthtech client work at bambybig.agency/clients.
For founders at seed to Series A+ who need their communications partner to support both their go-to-market and their next raise, that combination is rare and worth seeking out.
Choosing the right PR and marketing agency is one of the highest-leverage decisions a healthtech founder makes. The wrong partner costs positioning, compliance confidence, and the trust of buyers who already approach your industry with skepticism.
The right partner builds narrative capital from day one, amplifies every placement into compounding visibility, operates across clinical, tech, and investor media simultaneously, and connects your PR activity directly to your fundraising timeline. That combination is rare.
When you are ready to talk to a team that has built narrative capital for venture-backed healthtech companies at every stage: Book a consultation with BAM and find out how we can amplify your stories.
What should a healthtech startup look for in a PR agency?
Look for narrative depth, amplification strategy, media relationships across health, tech, and investor outlets, and a clear way to support fundraising visibility. In healthtech, credibility has to serve multiple buyers at once, so the agency should understand how to build trust with clinicians, operators, and investors.
Why does investor visibility matter in healthtech PR?
Investor visibility matters because PR is often tied to fundraising momentum in venture-backed healthtech. The right agency should know how to put founders in front of relevant reporters, investors, and event audiences so coverage and relationships support the next raise, not just awareness.
How is healthtech PR different from general B2B PR?
Healthtech PR has more complexity because the story has to work across regulated environments, longer sales cycles, and multiple stakeholders. The best agencies can translate clinical and economic proof into a narrative that resonates with buyers, partners, and capital providers.
What red flags should healthtech founders watch for?
Red flags include shallow narrative work, weak post-placement amplification, media relationships in only one lane, and no clear investor visibility strategy. If the agency cannot explain how it turns coverage into compounding value, it is probably not built for healthtech.
How can BAM help healthtech startups?
BAM helps healthtech startups build narrative capital, amplify coverage, connect with the right reporters, and create investor visibility through events and VC relationships. The point is not just to get press, but to turn it into meaningful momentum for growth and fundraising. See BAM's healthtech client work.